Lesley Marson
Principal investigator, leads Dignify Therapeutics LLC.
BiotechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$7.4MFederal grants as PI13 awards
0Patents grantedNone matched
123Papers3,511 citations
Federal awards and patents by year
AwardsPatents
13 awards · $7.4M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 21, 2020 | NIH | SBIR Phase I Neurokinin-2 receptor-induced micturition and defecation in aged diabetic rats | $296K | Dignify Therapeutics LLC |
| Sep 21, 2020 | NIH | SBIR Phase I Neurokinin-2 receptor-induced micturition and defecation in aged diabetic rats | $244K | Dignify Therapeutics LLC |
| Sep 25, 2019 | NIH | SBIR Phase I Intrarectal mechanoreceptor sensitization to induce defecation after spinal injury | $300K | Dignify Therapeutics LLC |
| Aug 4, 2017 | NIH | STTR Phase II Delivery of peptides for inducing voiding associated with neurological retention | $411K | Dignify Therapeutics LLC |
| Jul 12, 2017 | NIH | SBIR Phase II Development of a treatment for voiding dysfunction in spinal cord injured patients | $682K | Dignify Therapeutics LLC |
| Sep 30, 2016 | NIH | STTR Phase II Delivery of peptides for inducing voiding associated with neurological retention | $1.4M | Dignify Therapeutics LLC with UNIV OF NORTH CAROLINA CHAPEL HILL |
| Sep 21, 2016 | NIH | STTR Phase II Delivery of peptides for inducing voiding associated with neurological retention | $953K | Dignify Therapeutics LLC |
| Jul 7, 2016 | NIH | SBIR Phase II Development of a treatment for voiding dysfunction in spinal cord injured patients | $1.5M | Dignify Therapeutics LLC |
| Jul 6, 2016 | NIH | SBIR Phase II Development of a treatment for voiding dysfunction in spinal cord injured patients | $818K | Dignify Therapeutics LLC |
| May 1, 2015 | NIH | SBIR Phase I Development of potential delivery methods for treating voiding dysfunction associated with SCI | $199K | Dignify Therapeutics LLC |
| Apr 22, 2015 | NIH | SBIR Phase I Development of potential delivery methods for treating voiding dysfunction associated with SCI | $199K | Dignify Therapeutics LLC |
| Apr 15, 2015 | NIH | STTR Phase I Delivery of peptides for inducing voiding associated with neurological retention | $225K | Dignify Therapeutics LLC with UNIV OF NORTH CAROLINA CHAPEL HILL |
| Apr 6, 2015 | NIH | STTR Phase I Delivery of peptides for inducing voiding associated with neurological retention | $225K | Dignify Therapeutics LLC |
1 patents as inventor
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#129
Awards as PI#72
Patents#273
Companies
- Dignify Therapeutics LLCLeads (SEC Form D) · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.